UnknownPHASE2, PHASE3NCT01359345

Nephrogenic Systemic Fibrosis With Gadollinum

Studying Nephrogenic systemic fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Imam Khomeini Hospital
Principal Investigator
Mohammad R Khatami, MD
TUMS
Intervention
gadollinum(drug)
Enrollment
200 enrolled
Eligibility
18 years · All sexes
Timeline
2008 – 2012

Study locations (1)

Collaborators

Tehran Heart Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01359345 on ClinicalTrials.gov
← Back to all trials